FIELD: chemistry.
SUBSTANCE: invention relates to biotechnology, specifically to immunostimulating compounds and may be used in medicine. An immunostimulating peptide of an amino acid sequence XLYDKGYTSKEQKDCVGI, where N-terminal X is N-acetylalanine, and may be covalently linked to fatty acids, selected from C2-C25, to form PDAG (peptidyl-2,3-diacylglycerides). The resulted compound may be included in pharmaceutical formulations for stimulating an immune response.
EFFECT: invention provides efficient stimulation of an immune response in subjects and may enhance the immunogenicity of the antigenic peptide when administered with PDAG.
29 cl, 10 dwg, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BIOLOGICALLY ACTIVATED DRUGS BASED ON CYTOKINES AND METHODS OF USING THEM | 2019 |
|
RU2819307C2 |
| MODIFIED MELK PEPTIDES AND VACCINES CONTAINING LATTER | 2011 |
|
RU2580035C2 |
| ANTIBODIES AGAINST TNF-α AND USE THEREOF | 2010 |
|
RU2595379C2 |
| SOLUBLE MEDIATOR | 2012 |
|
RU2660580C2 |
| ANTI-VEGF ANTIBODIES AND APPLICATIONS THEREOF | 2010 |
|
RU2567639C2 |
| NOVEL PEPTIDES FOR TREATING AND PREVENTING IMMUNE-ASSOCIATED DISEASES, INCLUDING TREATMENT AND PREVENTION OF INFECTION BY MODULATING NATURAL IMMUNITY | 2006 |
|
RU2507213C2 |
| APPLICATION OF CALCITONIN AS COMBINED THERAPY FOR TREATMENT OF INFLAMMATORY DISEASE STATES | 2006 |
|
RU2394591C2 |
| FUSED DRUG CONSTRUCTS AND CONJUGATES | 2005 |
|
RU2428431C2 |
| ANTIGEN TAU-PEPTIDES AND THEIR APPLICATION | 2010 |
|
RU2518291C2 |
| RECEPTOR FOR VISTA | 2019 |
|
RU2812846C2 |
